Notably, analyses using the xCELLigence system confirmed the ability of CC-3 to mediate target efficacy of CC-3 over extended time periods, which indicates that CC-3 may induce sustained anti-tumor efficacy (Figure 5B). The gene discussed is CXCR1; the disease is neoplasm.